RedChip Visibility Issues Fourth Quarter 2007 Research Update on Pressure BioSciences, Inc. (PBIO)
RedChip Visibility recently issued a fourth quarter 2007 research update on Pressure BioSciences, Inc. (NASDAQ: PBIO), a life sciences company focusing exclusively on the development and commercialization of pressure cycling technology, reinstating their “Speculative Buy” rating and 12-month target price of $10.00 per share. The report also stated that PBIO reported more than a threefold year-over-year increase in revenues in the fourth quarter of 2007 as a result of the company's strong commercialization strategy with an expanded sales force and efficient research and development staff. Pressure BioSciences’s pressure cycling technology (PCT) has multiple applications, including genomic and proteomic sample preparation,…